pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Preclinical
NTM-005
Pain
Neumentum Inc
0
catalysts
Phase 2
NTM-006
Post-Operative Pain
Neumentum Inc
0
catalysts
Phase 3
NTO-1151
Triapine
Cervical Cancer
Ribonucleotide reductase
Resilience Government Services Inc
0
catalysts
Phase 1
← prev
page 132 of 271
next →
131
Pain
89
Neurology
1
NTP-42
Pulmonary Arterial Hypertension
ATXA Therapeutics Ltd
0
catalysts
Phase 1
NTS-1104
Acute Ischemic Stroke
NeuroTrauma Sciences LLC
0
catalysts
Phase 3
NTX-001
Peripheral Nerve Injury
Neuraptive Therapeutics Inc
0
catalysts
Phase 2
NTX-1472
Social Anxiety Disorder (SAD/Social Phobia)
Newleos Therapeutics Inc
0
catalysts
Phase 2
NTX-301
Chronic Myelomonocytic Leukemia (CMML)
Pinotbio Inc
0
catalysts
Preclinical
NTY-184
Major Depressive Disorder
Neuromity Therapeutics Inc
0
catalysts
Preclinical
NU-001
Ovarian Cancer
NUAgo Therapeutics Inc
0
catalysts
Preclinical
NU-01
Heavy Metal Poisoning
Medesis Pharma SA
0
catalysts
phase_0
NU-0129
Gliosarcoma
Northwestern University
0
catalysts
Preclinical
NU-02
Heavy Metal Poisoning
Medesis Pharma SA
0
catalysts
NUCYNTA
NUCYNTA (TAPENTADOL HYDROCHLORIDE)
1 INDICATIONS AND USAGE NUCYNTA (tapentadol) tablets are indicated for the ma…
Sodium-dependent noradrenaline transporter
Mu-type opioid receptor
$COLL
COLLEGIUM PHARMACEUTICAL, INC
0
catalysts
NUCYNTA ER
NUCYNTA ER (TAPENTADOL HYDROCHLORIDE)
1 INDICATIONS AND USAGE NUCYNTA ER (tapentadol) is indicated for the manageme…
Sodium-dependent noradrenaline transporter
Mu-type opioid receptor
$COLL
COLLEGIUM PHARMACEUTICAL, INC
0
catalysts
NURTEC ODT
NURTEC ODT (RIMEGEPANT SULFATE)
1 INDICATIONS AND USAGE NURTEC ODT is a calcitonin gene-related peptide recep…
Calcitonin gene-related peptide type 1 receptor
$PFE
PFIZER INC
0
catalysts
Preclinical
NV-101
Ewing Sarcoma
Oncology Pharma Inc
0
catalysts
Preclinical
NV-354
Subacute Necrotizing Encephalomyelopathy (Leigh Disease)
Abliva AB
0
catalysts
Preclinical
NV-360
Herpes Zoster (Shingles)
$NNVC
NANOVIRICIDES, INC.
0
catalysts
Preclinical
NVCov-2R
remdesivir
Coronavirus Disease 2019 (COVID-19)
$NNVC
NANOVIRICIDES, INC.
0
catalysts
Phase 3
NVD-003
Pseudarthrosis (Nonunion of Fracture/Pseudoarthrosis)
Novadip Biosciences SA
0
catalysts
Phase 2
NVG-291
Chronic Spinal Cord Injury
$NGEN
NERVGEN PHARMA CORP.
0
catalysts
Preclinical
NVK-006
Unspecified Infectious Diseases
Nevakar Injectables Inc
0
catalysts
Phase 1
NVK-029
Presbyopia
Vyluma Inc
0
catalysts
Phase 1
NVK-031
Unspecified Ophthalmological Disorders
Vyluma Inc
0
catalysts
Preclinical
NVPLC-2767
Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH)
NVP Healthcare Co Ltd
0
catalysts
Preclinical
NVX-101
rifampicin
Age Related Macular Degeneration
NeoVascularX Inc
0
catalysts
Phase 2
NVX-108
perflenapent
Glioblastoma Multiforme (GBM)
NuvOx Pharma LLC
0
catalysts
Phase 2
NVX-208
perflenapent
Acute Ischemic Stroke
NuvOx Pharma LLC
0
catalysts
Phase 1
NX-1607
Adenocarcinoma Of The Gastroesophageal Junction
$NRIX
Nurix Therapeutics, Inc.
0
catalysts
